You are here

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, June 19, 2023 - 12:00
Conditions:   Limbal Stem-cell Deficiency;   Congenital Aniridia
Interventions:   Procedure: transplantation of a Descemet's Membrane corneal onlay, partial LSCD;   Procedure: transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD
Sponsor:   University of Minnesota
Not yet recruiting
Posted: Monday, March 27, 2023 - 12:00
Conditions:   Mesenchymal Stem Cell;   Dry Eye Syndromes
Intervention:   Drug: MSCs eye drops
Sponsor:   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting
Posted: Wednesday, February 22, 2023 - 12:00
Condition:   Dry Eye Disease
Intervention:   Drug: Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Zhejiang University;   Hangzhou yuansheng biotechnology Co., Ltd
Not yet recruiting
Posted: Monday, January 30, 2023 - 12:00
Condition:   Corneal Ulcer
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Control Solution
Sponsors:   University of Illinois at Chicago;   United States Department of Defense
Not yet recruiting
Posted: Tuesday, December 20, 2022 - 12:00
Condition:   Myopic Chorioretinal Atrophy
Intervention:   Procedure: Pars plana vitrectomy
Sponsor:   PharmaBio Corporation
Not yet recruiting
Posted: Thursday, June 9, 2022 - 12:00
Condition:   Retinitis Pigmentosa
Interventions:   Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cells;   Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes;   Other: Placebo
Sponsor:   TC Erciyes University
Not yet recruiting
Posted: Tuesday, March 15, 2022 - 12:00
Conditions:   Ophthalmological Disorder;   Corneal Dystrophy;   Treatment;   Therapy;   Keratoconus
Interventions:   Procedure: Implantation;   Procedure: Lipoaspiration
Sponsors:   Vissum, Instituto Oftalmológico de Alicante;   Universidad Miguel Hernandez de Elche;   Instituto de Salud Carlos III
Not yet recruiting
Posted: Tuesday, January 11, 2022 - 12:00
Condition:   Age-Related Macular Degeneration
Interventions:   Biological: Cultured retinal stem and progenitor cells;   Other: Standard treatment according to the clinical protocols
Sponsors:   Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus;   Belarusian State Medical University
Not yet recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Conditions:   Eye Diseases;   Retinitis Pigmentosa;   Glaucoma;   Diabetic Retinopathy;   Macular Degeneration;   Traumatic Optic Neuropathy;   Optic Atrophy
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Friday, October 1, 2021 - 12:00
Conditions:   Eye Health;   Age-related Macular Degeneration
Interventions:   Dietary Supplement: Freeze-dried table grape powder;   Dietary Supplement: Placebo of the table grape powder
Sponsors:   National University, Singapore;   National University Hospital, Singapore;   Ministry of Education, Singapore
Not yet recruiting

Pages